Work

From Dose to Exposure: Shifting the Paradigm of Pediatric Clinical Pharmacology Research and Education

Year: 2024

Type: article

Abstract: Dr Tang Girdwood is the site PI of two clinical trials sponsored by Kaizen Bioscience, Inc. and Pfizer, Inc, but these studies had no influence on this work. All other authors declared no competing interests for this work.

Source: Clinical Pharmacology & Therapeutics

DOI: 10.1002/cpt.3281

Authors: Ronaldo Morales Junior, Victor Amajor, Kelli Paice, Kathryn E. Kyler, H. Rhodes Hambrick, Kathryn E. Pavia, Andrew S. Haynes, Felicia Gooden, Gwendolyn M. Pais, Kevin J. Downes, Laura B. Ramsey, Jonathan Wagner, Sonya Tang Girdwood

Institutions: Cincinnati Children's Hospital Medical Center, Children's Hospital of Philadelphia, Children's Mercy Hospital, University of Missouri–Kansas City, Children's Hospital Colorado, University of Colorado Anschutz, University of Cincinnati, Midwestern University, University of Pennsylvania

Language: English

Topic: Pharmaceutical studies and practices

Subfield: Pediatrics, Perinatology and Child Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development

Awards: Research Training in Pediatric Nephrology, T32 Cincinnati Pediatric Clinical Pharmacology Training Program, Children's Mercy Hospital Collaborative Fellowship Program in Pediatric Pharmacology, Clinical Pharmacology Training Program, Clinical Pharmacology K12 Training Program, Antibiotic Model-Informed Precision Dosing in Critical Illness

OpenAlex ID: W4396494683

FWCI: 2.022

Cites: 10

Cited by: 3

Related to: 10